title: Spindle cell oncocytomas and granular cell tumors of the pituitary are variants of pituicytoma.
abstract: Pituicytomas are neoplasms that arise from pituicytes, which are specialized glia of the posterior pituitary. Pituicytes have 5 ultrastructural variants: light, dark, granular, ependymal, and oncocytic. Granular cell tumors of the pituitary gland are thought to arise from granular pituicytes. Spindle cell oncocytomas are considered to arise from folliculostellate cells, which are sustentacular cells of the adenohypophysis. Recent data suggest that, whereas pituicytes and all 3 tumor types are positive for TTF-1, folliculostellate cells are negative for TTF-1. We investigated 7 spindle cell oncocytomas, 4 pituicytomas, and 3 granular cell tumors for their genetic (BRAF(V600E) mutation and BRAF-KIAA fusion), immunohistochemical (GFAP, vimentin, S100 protein, olig2, IDH1-R132H, NF, galectin-3, chromogranin-A, CD56, EMA, CAM5.2, CD68, TTF-1, and bcl-2), and ultrastructural features to refine their classification. All tumors had nuclear positivity for TTF-1 and were negative for CAM5.2, chromogranin-A, and NF. GFAP, vimentin, S100, galectin-3, EMA, and CD68 were variably positive in the majority of the 3 tumor groups. Olig2 was only positive in 1 pituicytoma. Whereas granular cell tumors were negative for bcl-2 and CD56, pituicytomas and spindle cell oncocytomas showed variable positivity. All tumors were negative with the IDH1-R132H mutation-specific antibody, and none had evidence of BRAF alterations (BRAF(V600E) mutation and BRAF-KIAA fusion). Diffuse TTF-1 expression in nontumorous pituicytes, pituicytomas, spindle cell oncocytomas, and granular cell tumors indicates a common pituicyte lineage. The ultrastructural variants of pituicytes are reflected in these 3 morphologic variants of tumors arising from these cells. We propose the terminology "oncocytic pituicytomas" and "granular cell pituicytomas" to refine the classification of these lesions.
authors.affiliation: *Department of Pathology, University Health Network, Toronto, ON, Canada †Department of Pathology, University of Virginia Health System, Charlottesville, VA.
authors.forename: Ozgur
authors.initials: O
authors.lastname: Mete
authors.forename: Maria Beatriz
authors.initials: MB
authors.lastname: Lopes
authors.forename: Sylvia L
authors.initials: SL
authors.lastname: Asa
mesh_terms: D018249:Adenoma, Oxyphilic / Q000737:chemistry / Q000145:classification / Q000235:genetics / Q000473:pathology* / Q000648:ultrastructure; D014408:Biomarkers, Tumor / Q000032:analysis / Q000235:genetics; D001706:Biopsy; D004252:DNA Mutational Analysis; D016586:Granular Cell Tumor / Q000737:chemistry / Q000145:classification / Q000235:genetics / Q000473:pathology* / Q000648:ultrastructure; D006801:Humans; D007150:Immunohistochemistry; D008854:Microscopy, Electron; D009154:Mutation; D015514:Oncogene Proteins, Fusion / Q000235:genetics; D010911:Pituitary Neoplasms / Q000737:chemistry / Q000145:classification / Q000235:genetics / Q000473:pathology* / Q000648:ultrastructure; D011237:Predictive Value of Tests; D009626:Terminology as Topic
chemical_list: D014408:Biomarkers, Tumor; D015514:Oncogene Proteins, Fusion